Suven Pharmaceuticals Limited Financial Flexibility Index
Suven Pharmaceuticals Limited financial flexibility index. Suven Pharmaceuticals Limited (SUVENPHAR) has a Financial Flexibility Index of 0.33x as of December 2023. Free cash flow of Rs255.04 Million (operating CF Rs255.04 Million minus capex Rs0.00) represents 0% of total liabilities (Rs765.00 Million). See Suven Pharmaceuticals Limited free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Suven Pharmaceuticals Limited (2019–2025)
Financial flexibility index of Suven Pharmaceuticals Limited from 2019 to 2025. Historical Financial Flexibility Index trend for Suven Pharmaceuticals Limited across 7 annual periods. Check SUVENPHAR cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Suven Pharmaceuticals Limited Financial Flexibility Index by Year (2019–2025)
Suven Pharmaceuticals Limited financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Suven Pharmaceuticals Limited. For the full cash flow conversion analysis, see Suven Pharmaceuticals Limited cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | Rs4.44 Billion | Rs2.88 Billion | Rs11.91 Billion | ▼ -81.5% |
| 2024 | 2.02x | Rs4.10 Billion | Rs3.58 Billion | Rs2.03 Billion | ▼ -36.9% |
| 2023 | 3.20x | Rs7.37 Billion | Rs4.51 Billion | Rs2.31 Billion | ▲ +138.5% |
| 2022 | 1.34x | Rs4.05 Billion | Rs3.30 Billion | Rs3.02 Billion | ▼ -20.4% |
| 2021 | 1.68x | Rs4.94 Billion | Rs3.83 Billion | Rs2.94 Billion | ▲ +7.1% |
| 2020 | 1.57x | Rs5.15 Billion | Rs4.16 Billion | Rs3.28 Billion | ▲ +182.5% |
| 2019 | 0.56x | Rs1.07 Billion | Rs504.05 Million | Rs1.93 Billion | — |